Abstract:Background: Although antihypertensive medication use is associated with a lower risk of dementia in observational studies, such an effect is rarely found in randomized controlled trials (RCTs). As midlife high blood pressure is more predictive of incident dementia than hypertension in late life, so midlife hypertension may be the target for intervention. However, no such an RCT has been conducted to prevent incident dementia through reducing high blood pressure from midlife. Therefore, we aimed to emulate a target trial with an observational study design to estimate the effect of initiating antihypertensive medication from midlife on reducing incident dementia. Hypothesis: We assessed the hypothesis that newly initiating antihypertensive medication among midlife adults with hypertension reduces incident dementia. Methods: New-user design was used to emulate a target trial using data from the Health and Retirement Study from 1996 to 2018 with non-institutional dementia-free participants aged 45 to 65 years without taking antihypertensive medication in past two years. Participants with information of self-reported hypertension diagnosis and new use of antihypertensive medication, as well as no dementia based on algorithm were included in the analysis and represented group with/without initiating antihypertensive medication. An intention-to-treat approach was applied for analysis, and sequential emulation was used to increase the efficiency of intention-to-treat analysis. Proportional hazards models were applied to estimate the effect of initiating antihypertensive medication on incident dementia. Inverse probability of treatment and censoring weights were created to adjust for confounding and selection bias due to loss to follow-up, and death was considered as a competing event. Another emulated target trial with the same specifications was conducted among late-life adults aged 66 years or older for comparison. Results: A total of 3,151 non-unique participants (baseline mean age: 59.0 ± 4.0 years, 54.6% (n=1,719) women, 78.3% (n=2468) Whites, 71.4% (n=2,249) initiating antihypertensive medication) were included in the analysis. Initiating antihypertensive medication showed benefit in reducing incident dementia over a total of 22-year follow-up, with a reduction of risk by 19% (hazards ratio=0.81, 95% confidence interval: 0.66, 0.99). No significant reduction was observed for initiators of antihypertensive medication from late life. Conclusions: Initiating antihypertensive medication from midlife, but not from late life may reduce incident dementia. Future studies are warranted to estimate the effect of blood pressure lowering in midlife through other means of intervention in reducing incident dementia.

Effect of Combined Antihypertensive and Lipid-Lowering Therapies on Cognitive Function: A New Treatment Strategy?

Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial.

Effects of HMG-CoA Reductase Inhibitors on Primary Hypertension Patients with Vascular Cognitive Impairment

Hypertension and Mild Cognitive Impairment: State-of-the-Art Review

Effects of Combined Anti-Hypertensive and Statin Treatment on Memory, Fear Extinction, Adult Neurogenesis, and Angiogenesis in Adult and Middle-Aged Mice

Effects of Plasma Lipids and Statins on Cognitive Function

Effects of Hypertension on Alzheimer's Disease: Updates in Pathophysiological and Neuroimaging Findings

Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden

Antihypertensive Treatment and Prevention of Stroke and Dementia

Effect of stratified blood pressure control on cognitive dysfunction in patients with cerebral small vessel disease

Antihypertensive medications and dementia in older adults with hypertension

Trajectories of Cognitive Decline Before and After New-onset Hypertension

Abstract 54: Newly Initiation of Antihypertensive Medication on Reduction of Incident Dementia: Emulation of Target Trials Based on the Health and Retirement Study

Evaluation of High Cholesterol and Risk of Dementia and Cognitive Decline in Older Adults Using Individual Patient Meta-Analysis.

Effects of Sartans and Low-Dose Statins on Cerebral White Matter Hyperintensities and Cognitive Function in Older Patients with Hypertension: a Randomized, Double-Blind and Placebo-Controlled Clinical Trial

What have clinical trials taught us about brain health?

Efficacy and Mechanisms of Combined Aerobic Exercise and Cognitive Training in Mild Cognitive Impairment: Study Protocol of the ACT Trial

Overview the effect of statin therapy on dementia risk, cognitive changes and its pathologic change: a systematic review and meta-analysis.

Hypertension and Cognitive Impairment: A Review of Mechanisms and Key Concepts

Effects of cilostazol on cognitive function and dementia risk: A systematic review and meta-analysis

Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention